Atara Biotherapeutics, Inc. (ATRA) Financials

ATRA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 20.0 million 57.3 million
Dec. 31, 2025 20.2 million 58.7 million
Sept. 30, 2025 30.2 million 66.8 million
June 30, 2025 36.9 million 71.9 million

ATRA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -3.1 million 749000
Dec. 31, 2025 -5.7 million 1.5 million
Sept. 30, 2025 -9.8 million 1.2 million
June 30, 2025 -7.3 million 2.8 million

ATRA Net Income

No data available :(

ATRA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 8.4 million 9.1 million 10.1 million
Dec. 31, 2025 8.5 million 32.7 million 9.3 million
Sept. 30, 2025 13.7 million 32.0 million 15.0 million
June 30, 2025 22.3 million - 17.7 million

ATRA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 14.1 million
Dec. 31, 2025 12.7 million
Sept. 30, 2025 13.6 million
June 30, 2025 12.3 million

ATRA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 164000 3.6 million -
Dec. 31, 2025 - -223000 4.3 million -
Sept. 30, 2025 - 2.9 million 4.0 million -
June 30, 2025 - 7.3 million 5.9 million -

ATRA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 516000 124000
Dec. 31, 2025 1.6 million 104000
Sept. 30, 2025 3.5 million 115000
June 30, 2025 17.6 million 554000

ATRA

Price: $10.07

52 week price:
3.92
19.15

Earnings Per Share: -1.22 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 783100

Ebitda: -31.4 million

Market Capitalization: 89.4 million

Links: